368 related articles for article (PubMed ID: 29921511)
1. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Li N; Zhan X; Zhan X
Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas.
Li N; Li H; Cao L; Zhan X
Endocr Relat Cancer; 2018 Oct; 25(10):909-931. PubMed ID: 29997262
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis.
Zhan X; Li H; Qian S; Zhan X; Li N
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31789316
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
6. LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.
Wang H; Fu Z; Dai C; Cao J; Liu X; Xu J; Lv M; Gu Y; Zhang J; Hua X; Jia G; Xu S; Jia X; Xu P
Sci Rep; 2016 Dec; 6():38983. PubMed ID: 27941916
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
10. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.
Liu Y; Wang Y; Yao D; Cui D
Mol Med Rep; 2018 Jun; 17(6):8282-8288. PubMed ID: 29693704
[TBL] [Abstract][Full Text] [Related]
11. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
Liu L; Ni J; He X
Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.
Gao Y; Meng H; Liu S; Hu J; Zhang Y; Jiao T; Liu Y; Ou J; Wang D; Yao L; Liu S; Hui N
Hum Mol Genet; 2015 Feb; 24(3):841-52. PubMed ID: 25292198
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
15. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Zhang T; Cao C; Wu D; Liu L
Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.
Pastò A; Bellio C; Pilotto G; Ciminale V; Silic-Benussi M; Guzzo G; Rasola A; Frasson C; Nardo G; Zulato E; Nicoletto MO; Manicone M; Indraccolo S; Amadori A
Oncotarget; 2014 Jun; 5(12):4305-19. PubMed ID: 24946808
[TBL] [Abstract][Full Text] [Related]
17. Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.
Hearn JM; Romero-Canelón I; Munro AF; Fu Y; Pizarro AM; Garnett MJ; McDermott U; Carragher NO; Sadler PJ
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3800-5. PubMed ID: 26162681
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries.
Liu X; Dai C; Jia G; Xu S; Fu Z; Xu J; Li Q; Ruan H; Xu P
Oncol Rep; 2017 Aug; 38(2):799-808. PubMed ID: 28656240
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
